The future of cancer treatment – combining stem cells and immunotherapy.
The company leads a Department of Industry, Innovation and Science Co-operative Research Centre project in partnership with the Hudson Institute of Medical Research, Monash University, Mesoblast Ltd and Cell Therapies Pty Ltd.
Cartherics is:
- Creating a new class of cancer treatments beyond surgery, chemotherapy, biologicals and radiation.
- Supercharging a patient’s own immune system, helping it eliminate cancer.
- Developing accessible ‘off-the-shelf’ immunotherapies to fight aggressive forms of cancers like relapsed ovarian and gastric cancers.
Transforming cancer from a fatal disease to a manageable condition.
Cell Therapy News/Articles, page-8332
-
- There are more pages in this discussion • 10,097 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |